Sunwin International Neutraceuticals, Inc., one of the world's leading producers of all natural, zero calorie stevia, today announced that it is actively seeking Generally Recognized as Safe (GRAS) status from the U.S. Food and Drug Administration (FDA) for its high grade Stevia Rebaudioside A extracts, including their Rebaudioside A 95% extract, commonly known as "Reb A 95."
GRAS Associates, LLC, a leading consultant for the food industry founded by two former senior scientists at FDA's GRAS Review Branch, has been retained to convene an Expert Panel of food safety scientists to undertake a GRAS assessment for Sunwin. The independent GRAS assessment is intended to ensure that FDA's food ingredient safety standard is met. The GRAS designation process involves an extensive review of published research and toxicology studies as well as international standards for the safe use of stevia in food and beverages, and a review of Sunwin's specific stevia extracts. According to Dr. Robert McQuate, GRAS Associates CEO and Co-Founder, "Recent advances in production of high purity sweeteners derived from stevia are quite impressive. Such compositional refinement, in concert with the expanded body of toxicology studies on the natural sweetener, will be carefully considered by our Expert Panel during its deliberations on the potential GRAS status of Sunwin's stevia extracts."
Stevia provides US consumers a zero-calorie all natural sweetener alternative to chemical based sweeteners commonly utilized in diet or low calorie products. Sunwin's stevia has been used around the world for years, but is a relatively new entrant to the US market with distribution in approximately 4,000 retail stores and use in Zevia beverages, among other products.
President of Sunwin's US subsidiary Jeff Reynolds commented, "Stevia has been used in countries around the world for decades without issue. It is a natural sweetener and provides a needed alternative to high calorie sweeteners and chemical sweetener alternatives. Sunwin's stevia provides the highest standards of quality for use as a tabletop product and in the food and beverage industry. With the recent US launch, there is rapidly growing interest in stevia while global production facilities capable of producing the quality and quantity of stevia for the US market remain limited. Sunwin's products have already entered the US as a dietary supplement, so GRAS status is the next logical step for our product lines. We look forward to expanding our product lines as well as the underlying production infrastructure and inventory in this product as it becomes more widely used."
Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine, zero calorie natural sweeteners (stevia), and veterinary medicines and feeds prepared from 100 percent organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. For more info about Sunwin, please visit http://www.sunwininternational.com
Safe Harbor Statement
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2008 and our reports on Form 10-Q.